11/04 Appointment of Phase I Clinical Trial CRO

Written By Rita Ray

https://www.linkedin.com/posts/oxford-cannabinoid-technologies_we-are-pleased-to-announce-that-oxford-cannabinoid-activity-7184160679895932928-RAwW?utm_source=share&utm_medium=member_desktop

Rita Ray
Previous

15/04 Oxford Cannabinoid Technologies Appoint CRO en route to Phase I Trials for Programme Two
Next

OCT Company Update with Doceo